[1] Johnston S L,Lock R J,Gompels M M.Takayasu arteritis: a review[J].J Clin Pathol,2002,55(7):481-486.
[2] Noris M.Pathogenesis of Takayasu's arteritis[J].J Nephrol,2001,14(6):506-513.
[3] 中华医学会风湿病学分会.大动脉炎诊断及治疗指南[J].中华风湿病学杂志,2011,15(2):119-120.
[4] Arend W P,Michel B A,Bloch D A,et al.The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis[J]. Arthritis Rheum, 1990, 33(8): 1129-1134.
[5] Ozen S,Pistorio A,Iusan S M,et al.EULAR/PRINTO/PRES criteria for Henoch-Schnlein purpura,childhood polyarteritisnodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis:Ankara 2008.Part Ⅱ:final classification criteria[J].Ann Rheum Dis,2010,69(5):798-806.
[6] 徐建萍,赵阳,李俊芳,等.大动脉炎合并中枢系统病变研究进展 [J].山西医药杂志,2017,46(8):900-902.
[7] Mahajan N,Dhawan V,Mahmood S,et al.Extracellular matrix remodeling in Takayasu 's arteritis:role of matrix metalloproteinases and adventitial inflammation[J].Arch Med Res,2012,43(5):406-410.
[8]Kong X,Sun Y,Ma L,et al.The critical role of IL-6 in the pathogenesis of Takayasu arteritis [J].Clin Exp Rheumatol,2016,34(3 Suppl 97):S21-S27.
[9] Alibaz-Oner F,Aksu K,Yentur S P,et al.Plasma pentraxin-3 levels in patients with Takayasu's arteritis during routine follow-up[J].Clin Exp Rheumatol,2016,34(3 Suppl 97):73-76.
[10] 马莉莉,戴晓敏,孙颖,等.脂肪因子与大动脉炎血管炎症相关性的临床分析[J].中华风湿病学杂志,2015,19(5):338-342. |
